3.8 Review

The HER3/ErbB3 receptor: A promising target in cancer drug therapy

Journal

GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
Volume 34, Issue 4-5, Pages 255-259

Publisher

MASSON EDITEUR
DOI: 10.1016/j.gcb.2010.03.002

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available